title: Yellowish nail pigmentation caused by sunitinib.
authors.affiliation: Skin Cancer and Cutaneous Toxicities of Cancer Therapy Unit, Department of Dermatology, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain. espinosapab@gmail.com.
authors.forename: Pablo
authors.initials: P
authors.lastname: Espinosa Lara
authors.affiliation: Department of Medical Oncology, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain.
authors.forename: Coralia
authors.initials: C
authors.lastname: Bueno
authors.affiliation: Department of Dermatology, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain.
authors.forename: Beatriz
authors.initials: B
authors.lastname: Aranegui
authors.affiliation: Department of Dermatology, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain.
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Vargas-Machuca
authors.affiliation: Department of Dermatology, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain.
authors.forename: José
authors.initials: J
authors.lastname: Jiménez Reyes
mesh_terms: D000368:Aged; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D009260:Nail Diseases / Q000139:chemically induced* / Q000175:diagnosis; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000175:diagnosis; D011758:Pyrroles / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D000077210:Sunitinib
chemical_list: D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib